About the Journal

International Journal of Pharmaceutical Research and Life Sciences (IJPRLS), an official journal of Rungta International Skills University, is a peer-reviewed, open-access journal dedicated to publishing high-quality original research, reviews, and short communications that advance scientific knowledge in the fields of pharmaceutical sciences and life sciences including pharmacology, pharmaceutics, medicinal chemistry, pharmacognosy, drug delivery, biotechnology, toxicology, biomedical sciences, interdisciplinary research in nanotechnology, drug discovery, and healthcare innovation. The journal provides a credible platform for researchers, academicians, clinicians, and industry professionals worldwide to disseminate innovative findings, foster interdisciplinary collaboration, and bridge the gap between laboratory research and real-world therapeutic applications.

IJPRLS welcomes original research articles, review articles, case studies, short communications, and mini-reviews across pharmaceutical sciences and life sciences. The journal is published biannually (twice a year) under a fully open-access model, with no subscription, access, or paywall charges for readers, and all manuscripts undergo a rigorous double-blind peer-review process.

Aims

The International Journal of Pharmaceutical Research and Life Sciences (IJPRLS), an official journal of Rungta International Skills University, is a peer-reviewed, open-access journal dedicated to publishing high-quality original research, reviews, and short communications that advance scientific knowledge in the fields of pharmaceutical sciences and life sciences. The journal aims to provide a credible platform for researchers, academicians, clinicians, and industry professionals worldwide to disseminate innovative findings, foster interdisciplinary collaboration, and bridge the gap between laboratory research and real-world therapeutic applications.

Scope

IJPRLS welcomes original research articles, review articles, case studies, short communications, and mini-reviews across (but not limited to) the following areas:

Pharmaceutical Sciences

Pharmaceutics and Novel Drug Delivery Systems
Pharmaceutical Chemistry and Drug Design
Pharmacology and Toxicology
Pharmacognosy and Phytochemistry
Pharmaceutical Analysis and Quality Control
Pharmaceutical Biotechnology
Clinical Pharmacy and Pharmacy Practice
Pharmacoeconomics and Pharmacoepidemiology
Regulatory Affairs and Pharmaceutical Jurisprudence
Nanotechnology in Drug Delivery
Herbal and Traditional Medicine

Life Sciences

Biotechnology and Genetic Engineering
Microbiology and Immunology
Biochemistry and Molecular Biology
Cell Biology and Physiology
Environmental and Marine Sciences
Bioinformatics and Computational Biology
Food Science and Nutrition
Public Health and Epidemiology
Zoology, Botany, and Agricultural Sciences
Biomedical Sciences and Clinical Research

Policies at a glance

Biannual: published twice a year, fully open access with no subscription or paywall charges.
Double-blind review: every manuscript is evaluated by at least two independent subject-matter experts.
20-day first review: the first review report and initial decision are provided within 20 days of submission.
≤ 10% similarity: zero tolerance for plagiarism; manuscripts above the threshold are returned or rejected.
Disclosed AI use: AI may only polish language and must be declared. AI tools cannot be listed as authors.
COPE ethics: retractions, appeals and complaints are handled following COPE guidelines.